Covered and Uncovered Self-Expandable Metallic Stents in the Treatment of Malignant Biliary Obstruction


Covered Metallic Stent
Uncovered Metallic Stent
Self-Expandable Metallic Stent (SEMS)
Malignant Biliary Obstruction
Biliary Stent

How to Cite

Qin , W.-Y. ., Li , J.-Z. ., Peng , W.-P. ., Zhang , M.-M. ., Lao , B. ., Hong , J.-M., & Li , L.-B. (2020). Covered and Uncovered Self-Expandable Metallic Stents in the Treatment of Malignant Biliary Obstruction. Iranian Red Crescent Medical Journal, 22(7). Retrieved from


Context: Self-expandable metal stents (SEMSs) are commonly used in the treatment of malignant biliary obstruction. We performed a meta-analysis to compare the efficacy of covered self-expandable metallic stents (CSEMSs) and uncovered self-expandable metallic stents (UCSEMSs) for patients with malignant distal biliary obstruction.

Methods: A comprehensive search was conducted using PubMed, Embase, Cochrane, and CNKI databases from 2010 to 2019. All randomized controlled trials, which compared the use of the CSEMSs and UCSEMSs for the treatment of malignant distal biliary obstruction were included in this study.

Results: This meta-analysis included 1,539 patients enrolled in 13 trials. There was no difference between the two groups in terms of patients’ survival (hazard ratio (HR) 0.96, 95% confidence interval (CI): 0.87 - 1.07; I2 = 32.6%), stent patency (HR 0.92, 95% CI: 0.69 - 1.22; I2 = 56.3%), and the overall complication rate (relative risks (RR) 1.35, 95% CI: 0.82 - 2.23; I2 = 0%). In particular, the CSEMSs group presented a lower rate of tumor ingrowth (RR 0.30, 95% CI: 0.15 - 0.57; I2 = 58.5%) than the UCSEMSs group. However, the CSEMSs group exhibited a higher rate of tumor overgrowth (RR 1.63, 95% CI: 1.00 - 2.66; I2 = 0%), sludge formation (RR 2.28, 95% CI: 1.36 - 3.82;

I2 = 0%), and migration (RR 5.14, 95% CI: 1.90 - 13.88; I2 = 0%).

Conclusions: Our meta-analysis indicated that there was no significant difference between the two stents, and each one had its advantages and disadvantages.



  1. Costamagna G, Tringali A, Reddy DN, Deviere J, Bruno M, Ponchon T, et al. A new partially covered nitinol stent for palliative treatment of malignant bile duct obstruction: A multicenter single-arm prospective study. Endoscopy. 2011;43(4):317-24. doi: 10.1055/s-0030-1256294. [PubMed: 21360423].
  2. Shim DJ, Gwon DI, Han K, Kim Y, Ko GY, Shin JH, et al. Percutaneous metallic stent placement for palliative management of malignant biliary hilar obstruction. Korean J Radiol. 2018;19(4):597-605. doi: 10.3348/kjr.2018.19.4.597. [PubMed: 29962866]. [PubMed Central: PMC6005945].
  3. Gwon DI, Ko GY, Kim JW, Ko HK, Yoon HK, Sung KB. Double-stent system with long duodenal extension for palliative treatment of malignant extrahepatic biliary obstructions: A prospective study. Korean J Radiol. 2018;19(2):230-6. doi: 10.3348/kjr.2018.19.2.230. [PubMed: 29520180]. [PubMed Central: PMC5840051].
  4. Soehendra N, Reynders-Frederix V. Palliative bile duct drainage - a new endoscopic method of introducing a transpapillary drain. Endoscopy. 1980;12(1):8-11. doi: 10.1055/s-2007-1021702. [PubMed: 7353562].
  5. Itoi T, Kasuya K, Abe Y, Isayama H. Endoscopic placement of a new short-term biodegradable pancreatic and biliary stent in an animal model: A preliminary feasibility study (with videos). J Hepatobiliary Pancreat Sci. 2011;18(3):463-7. doi: 10.1007/s00534-010-0364-3. [PubMed: 21170555].
  6. Sawas T, Al Halabi S, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: A meta-analysis. Gastrointest Endosc. 2015;82(2):256-267 e7. doi: 10.1016/j.gie.2015.03.1980. [PubMed: 25982849].
  7. Hong W, Sun X, Zhu Q. Endoscopic stenting for malignant hilar biliary obstruction: Should it be metal or plastic and unilateral or bilateral? Eur J Gastroenterol Hepatol. 2013;25(9):1105-12. doi: 10.1097/MEG.0b013e328360b9ec. [PubMed: 23542449].
  8. Crippa S, Cirocchi R, Partelli S, Petrone MC, Muffatti F, Renzi C, et al. Systematic review and meta-analysis of metal versus plastic stents for preoperative biliary drainage in resectable periampullary or pancreatic head tumors. Eur J Surg Oncol. 2016;42(9):1278-85. doi: 10.1016/j.ejso.2016.05.001. [PubMed: 27296728].
  9. Moss AC, Morris E, Leyden J, MacMathuna P. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;19(12):1119-24. doi: 10.1097/MEG.0b013e3282f16206. [PubMed: 17998839].
  10. Weber A, Mittermeyer T, Wagenpfeil S, Schmid RM, Prinz C. Self-expanding metal stents versus polyethylene stents for palliative treatment in patients with advanced pancreatic cancer. Pancreas. 2009;38(1):e7-e12. doi: 10.1097/MPA.0b013e3181870ab8. [PubMed: 18766117].
  11. Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53(5):729-34. doi: 10.1136/gut.2003.018945. [PubMed: 15082593]. [PubMed Central: PMC1774024].
  12. Krokidis M, Fanelli F, Orgera G, Tsetis D, Mouzas I, Bezzi M, et al. Percutaneous palliation of pancreatic head cancer: Randomized comparison of ePTFE/FEP-covered versus uncovered nitinol biliary stents. Cardiovasc Intervent Radiol. 2011;34(2):352-61. doi: 10.1007/s00270-010-9880-4. [PubMed: 20467870].
  13. Krokidis M, Fanelli F, Orgera G, Bezzi M, Passariello R, Hatzidakis A. Percutaneous treatment of malignant jaundice due to extrahepatic cholangiocarcinoma: Covered Viabil stent versus uncovered Wallstents. Cardiovasc Intervent Radiol. 2010;33(1):97-106. doi: 10.1007/s00270-009-9604-9. [PubMed: 19495871].
  14. Kitano M, Yamashita Y, Tanaka K, Konishi H, Yazumi S, Nakai Y, et al. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: A randomized multicenter trial. Am J Gastroenterol. 2013;108(11):1713-22. doi: 10.1038/ajg.2013.305. [PubMed: 24042190].
  15. Hu B, Wang TT, Wu J, Shi ZM, Gao DJ, Pan YM. Antireflux stents to reduce the risk of cholangitis in patients with malignant biliary strictures: A randomized trial. Endoscopy. 2014;46(2):120-6. doi: 10.1055/s-0034-1364872. [PubMed: 24477367].
  16. Kullman E, Frozanpor F, Soderlund C, Linder S, Sandstrom P, Lindhoff-Larsson A, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: Results from a randomized, multicenter study. Gastrointest Endosc. 2010;72(5):915-23. doi: 10.1016/j.gie.2010.07.036. [PubMed: 21034892].
  17. Telford JJ, Carr-Locke DL, Baron TH, Poneros JM, Bounds BC, Kelsey PB, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72(5):907-14. doi: 10.1016/j.gie.2010.08.021. [PubMed: 21034891].
  18. Lee SJ, Kim MD, Lee MS, Kim IJ, Park SI, Won JY, et al. Comparison of the efficacy of covered versus uncovered metallic stents in treating inoperable malignant common bile duct obstruction: A randomized trial. J Vasc Interv Radiol. 2014;25(12):1912-20. doi: 10.1016/j.jvir.2014.05.021. [PubMed: 25085230].
  19. Yang MJ, Kim JH, Yoo BM, Hwang JC, Yoo JH, Lee KS, et al. Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: A randomized controlled trial. Scand J Gastroenterol. 2015;50(12):1490-9. doi: 10.3109/00365521.2015.1057219. [PubMed: 26133200].
  20. Lee BS, Ryu JK, Jang DK, Chung KH, Yoon WJ, Kim J, et al. Reintervention for occluded metal stent in malignant bile duct obstruction: A prospective randomized trial comparing covered and uncovered metal stent. J Gastroenterol Hepatol. 2016;31(11):1901-7. doi: 10.1111/jgh.13392. [PubMed: 27029890].
  21. Conio M, Mangiavillano B, Caruso A, Filiberti RA, Baron TH, De Luca L, et al. Covered versus uncovered self-expandable metal stent for palliation of primary malignant extrahepatic biliary strictures: A randomized multicenter study. Gastrointest Endosc. 2018;88(2):283-291 e3. doi: 10.1016/j.gie.2018.03.029. [PubMed: 29653120].
  22. Chen MY, Lin JW, Zhu HP, Zhang B, Jiang GY, Yan PJ, et al. Covered stents versus uncovered stents for unresectable malignant biliary strictures: A meta-analysis. Biomed Res Int. 2016;2016:6408067. doi: 10.1155/2016/6408067. [PubMed: 27051667]. [PubMed Central: PMC4802019].
  23. Li J, Li T, Sun P, Yu Q, Wang K, Chang W, et al. Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: A meta-analysis. PLoS One. 2016;11(2). e0149066. doi: 10.1371/journal.pone.0149066. [PubMed: 26859673]. [PubMed Central: PMC4747571].
  24. Walter D, van Boeckel PG, Groenen MJ, Weusten BL, Witteman BJ, Tan G, et al. Cost efficacy of metal stents for palliation of extrahepatic bile duct obstruction in a randomized controlled trial. Gastroenterology. 2015;149(1):130-8. doi: 10.1053/j.gastro.2015.03.012. [PubMed: 25790742].
  25. Ung KA, Stotzer PO, Nilsson A, Gustavsson ML, Johnsson E. Covered and uncovered self-expandable metallic Hanarostents are equally efficacious in the drainage of extrahepatic malignant strictures. Results of a double-blind randomized study. Scand J Gastroenterol. 2013;48(4):459-65. doi: 10.3109/00365521.2012.758766. [PubMed: 23373541].
  26. Gardner TB, Spangler CC, Byanova KL, Ripple GH, Rockacy MJ, Levenick JM, et al. Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial. Gastrointest Endosc. 2016;84(3):460-6. doi: 10.1016/j.gie.2016.02.047. [PubMed: 26972022]. [PubMed Central: PMC4988865].
  27. Yoon WJ, Lee JK, Lee KH, Lee WJ, Ryu JK, Kim YT, et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc. 2006;63(7):996-1000. doi: 10.1016/j.gie.2005.11.054. [PubMed: 16733115].
  28. Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74(2):321-327 e1-3. doi: 10.1016/j.gie.2011.03.1249. [PubMed: 21683354].
  29. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: A prospective trial examining impact on quality of life. Gastrointest Endosc. 2002;56(6):835-41. doi: 10.1067/mge.2002.129868